| |
| |
|
| Insider
Information: |
Watts Ryan J. |
| Relationship: |
President and CEO, Dir... |
| City: |
South San Francisco |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
238,067 |
|
|
Indirect Shares
|
2,202,604 |
|
|
| Direct
Value |
$5,330,320 |
|
|
|
Indirect Value
|
$49,316,304 |
|
|
| Total
Shares |
2,440,671 |
|
|
| Total
Value |
$54,646,624 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
14
|
|
Stock
price went up :
|
0
|
4
|
| Stock
price went down : |
0
|
10
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
 110.6%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Denali Therapeutics Inc. |
DNLI |
President and CEO, Dir... |
2024-03-29 |
238,067 |
2024-03-29 |
2,202,604 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
76 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 3 of 4
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| DNLI |
Denali Therapeutics Inc. |
President and CEO |
• • – |
2023-08-10 |
4 |
AS |
$25.03 |
$63,226 |
I/I |
(2,526) |
2,239,913 |
0 |
% |
|
| DNLI |
Denali Therapeutics Inc. |
President and CEO |
• • – |
2023-04-21 |
4 |
AS |
$25.15 |
$623,720 |
I/I |
(24,800) |
2,239,913 |
0 |
% |
|
| DNLI |
Denali Therapeutics Inc. |
President and CEO |
• • – |
2019-04-03 |
4 |
AS |
$26.28 |
$161,630 |
I/I |
(6,141) |
2,597,638 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
President and CEO |
• • – |
2023-01-05 |
4 |
S |
$28.44 |
$136,512 |
I/I |
(4,800) |
2,223,664 |
0 |
% |
|
| DNLI |
Denali Therapeutics Inc. |
President and CEO |
• • – |
2023-01-04 |
4 |
S |
$28.73 |
$144,483 |
I/I |
(5,029) |
2,213,464 |
0 |
% |
|
| DNLI |
Denali Therapeutics Inc. |
President and CEO |
• • – |
2023-02-10 |
4 |
AS |
$29.10 |
$727,500 |
I/I |
(25,000) |
2,229,031 |
0 |
% |
|
| DNLI |
Denali Therapeutics Inc. |
President and CEO |
• • – |
2023-02-13 |
4 |
AS |
$30.08 |
$1,017,243 |
I/I |
(33,815) |
2,239,913 |
0 |
% |
|
| DNLI |
Denali Therapeutics Inc. |
President and CEO |
• • – |
2023-02-09 |
4 |
AS |
$30.59 |
$105,015 |
I/I |
(3,433) |
2,229,031 |
0 |
% |
|
| DNLI |
Denali Therapeutics Inc. |
President and CEO |
• • – |
2022-08-19 |
4 |
S |
$33.22 |
$79,861 |
I/I |
(2,404) |
2,202,993 |
0 |
% |
|
| DNLI |
Denali Therapeutics Inc. |
President and CEO |
• • – |
2022-02-11 |
4 |
S |
$34.72 |
$329,528 |
I/I |
(9,491) |
2,129,648 |
0 |
% |
|
| DNLI |
Denali Therapeutics Inc. |
President and CEO |
• • – |
2022-02-09 |
4 |
S |
$37.55 |
$102,104 |
I/I |
(2,719) |
2,119,442 |
0 |
% |
|
| DNLI |
Denali Therapeutics Inc. |
President and CEO |
• • – |
2021-12-01 |
4 |
AS |
$44.39 |
$823,581 |
I/I |
(18,333) |
2,103,368 |
0 |
% |
|
| DNLI |
Denali Therapeutics Inc. |
President and CEO |
• • – |
2022-01-05 |
4 |
S |
$44.78 |
$224,213 |
I/I |
(5,007) |
2,113,361 |
0 |
% |
|
| DNLI |
Denali Therapeutics Inc. |
President and CEO |
• • – |
2021-11-01 |
4 |
AS |
$48.61 |
$912,176 |
I/I |
(18,333) |
2,121,701 |
0 |
% |
|
| DNLI |
Denali Therapeutics Inc. |
President and CEO |
• • – |
2021-08-19 |
4 |
S |
$49.38 |
$117,769 |
I/I |
(2,376) |
2,176,700 |
0 |
% |
|
| DNLI |
Denali Therapeutics Inc. |
President and CEO |
• • – |
2021-10-01 |
4 |
AS |
$49.38 |
$923,550 |
I/I |
(18,333) |
2,140,034 |
0 |
% |
|
| DNLI |
Denali Therapeutics Inc. |
President and CEO |
• • – |
2021-08-02 |
4 |
AS |
$50.80 |
$942,477 |
I/I |
(18,333) |
2,174,076 |
0 |
% |
|
| DNLI |
Denali Therapeutics Inc. |
President and CEO |
• • – |
2021-09-01 |
4 |
AS |
$54.27 |
$1,002,012 |
I/I |
(18,333) |
2,158,367 |
0 |
% |
|
| DNLI |
Denali Therapeutics Inc. |
President and CEO |
• • – |
2021-05-03 |
4 |
AS |
$58.45 |
$1,075,102 |
I/I |
(18,333) |
2,229,075 |
0 |
% |
|
| DNLI |
Denali Therapeutics Inc. |
President and CEO |
• • – |
2021-06-01 |
4 |
AS |
$60.98 |
$1,125,648 |
I/I |
(18,333) |
2,210,742 |
0 |
% |
|
| DNLI |
Denali Therapeutics Inc. |
President and CEO |
• • – |
2021-03-01 |
4 |
AS |
$64.42 |
$1,216,551 |
I/I |
(18,334) |
2,305,742 |
0 |
% |
|
| DNLI |
Denali Therapeutics Inc. |
President and CEO |
• • – |
2021-01-04 |
4 |
AS |
$65.21 |
$6,621,782 |
I/I |
(88,334) |
2,322,978 |
0 |
% |
|
| DNLI |
Denali Therapeutics Inc. |
President and CEO |
• • – |
2021-02-01 |
4 |
AS |
$68.21 |
$1,254,819 |
I/I |
(18,334) |
2,304,649 |
0 |
% |
|
| DNLI |
Denali Therapeutics Inc. |
President and CEO |
• • – |
2021-02-11 |
4 |
S |
$70.17 |
$665,984 |
I/I |
(9,473) |
2,324,076 |
0 |
% |
|
| DNLI |
Denali Therapeutics Inc. |
President and CEO |
• • – |
2021-02-09 |
4 |
S |
$73.24 |
$377,211 |
I/I |
(5,112) |
2,313,853 |
0 |
% |
|
76 Records found
|
|
Page 3 of 4 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
